Q&A: Forbion Capital Partners' Sander Slootweg
Life-sciences-focused venture firm Forbion Capital Partners recently held a €360m final close for its fourth flagship fund, surpassing its initial hard-cap of €350m. Managing partner Sander Slootweg speaks to Francesca Veronesi about the fundraising process, the firm's 'build' strategy and the European life sciences venture market
More on Benelux
Brightlands Venture Partners IV holds €45m first close
Fund invests in renewable chemistry, regenerative medicine and agri-food across the Netherlands, Belgium and parts of Germany
Buyout rankings: who invested the most in Europe in Q1 2021?
Unquote tallies the top 10 most active GPs across the European buyout space in the first quarter
Altor sells Centralpoint to trade for €425m
GP intends to acquire a stake in acquirer Dustin, which Altor listed in 2015
BlackRock, Temasek launch decarbonisation fund platform
Decarbonization Partners has a fundraising target of $1bn for its first fund, including capital from Temasek and BlackRock
Latest News
Brightlands Venture Partners IV holds €45m first close
Fund invests in renewable chemistry, regenerative medicine and agri-food across the Netherlands, Belgium and parts of Germany
Battery Ventures buys IMC Test & Measurement
Company will operate with the GP's existing test and measurement companies in the US and Denmark
Tech overtakes consumer in Italy
Numerous Italian GPs with a generalist approach have reshaped their activity towards the tech sector
Resource Partners buys dog food maker Atlantic Products
GP plans to merge Atlantic with portfolio company Maced, in which it acquired a majority stake last year